오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - perindopril arginine, quantity: 10 mg - tablet, film coated - excipient ingredients: iron oxide yellow; colloidal anhydrous silica; hypromellose; isomalt; titanium dioxide; macrogol 8000; magnesium stearate; brilliant blue fcf aluminium lake; hyprolose - treatment of hypertension and the treatment of heart failure. in such patients it is recommended that perindopril arginine be given with a diuretic and/or digoxin under close medical supervision. (the safety and efficacy of perindopril arginine has not been demonstrated for new york heart association category iv patients); and patients with established coronary artery disease (see clinical trials) who are stable on concomitant therapy and have no heart failure, to reduce the risk of non-fatal myocardial infarction or cardiac arrest.

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - perindopril arginine, quantity: 10 mg - tablet, film coated - excipient ingredients: lactose monohydrate; sodium starch glycollate type a; maltodextrin; magnesium stearate; glycerol dibehenate; colloidal anhydrous silica; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350 - the treatment of hypertension; the treatment of heart failure. in such patients it is recommended that perindopril be given with a diuretic and/or digoxin under close medical supervision. (the safety and efficacy of perindopril arginine has not been demonstrated for new york heart association category iv patients); and patients with established coronary artery disease (see clinical trials) who are stable on concomitant therapy and have no heart failure, to reduce the risk of non-fatal myocardial infarction or cardiac arrest.

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - perindopril arginine, quantity: 10 mg - tablet, film coated - excipient ingredients: colloidal anhydrous silica; magnesium stearate; lactose monohydrate; glycerol dibehenate; sodium starch glycollate type a; maltodextrin; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350 - the treatment of hypertension; the treatment of heart failure. in such patients it is recommended that perindopril be given with a diuretic and/or digoxin under close medical supervision. (the safety and efficacy of perindopril arginine has not been demonstrated for new york heart association category iv patients); and patients with established coronary artery disease (see clinical trials) who are stable on concomitant therapy and have no heart failure, to reduce the risk of non-fatal myocardial infarction or cardiac arrest.

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - amlodipine besilate, quantity: 6.94 mg; perindopril arginine, quantity: 10 mg - tablet - excipient ingredients: trehalose dihydrate; crospovidone; sodium starch glycollate; calcium hydrogen phosphate; magnesium stearate; light magnesium oxide; microcrystalline cellulose; glycerol dibehenate - perindopril/amlodipine is indicated as substitution therapy for the treatment of hypertension and/or stable coronary heart disease in patients already controlled with separate doses of perindopril and amlodipine, given concurrently at the same dose level. treatment should not be initiated with this combination.

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - amlodipine besilate, quantity: 6.94 mg; perindopril arginine, quantity: 10 mg - tablet - excipient ingredients: light magnesium oxide; magnesium stearate; microcrystalline cellulose; calcium hydrogen phosphate; glycerol dibehenate; sodium starch glycollate; crospovidone; trehalose dihydrate - perindopril/amlodipine is indicated as substitution therapy for the treatment of hypertension and/or stable coronary heart disease in patients already controlled with separate doses of perindopril and amlodipine, given concurrently at the same dose level. treatment should not be initiated with this combination.

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - amlodipine besilate, quantity: 6.94 mg; perindopril arginine, quantity: 5 mg - tablet - excipient ingredients: trehalose dihydrate; calcium hydrogen phosphate; magnesium stearate; sodium starch glycollate; microcrystalline cellulose; crospovidone; light magnesium oxide; glycerol dibehenate - perindopril/amlodipine is indicated as substitution therapy for the treatment of hypertension and/or stable coronary heart disease in patients already controlled with separate doses of perindopril and amlodipine, given concurrently at the same dose level. treatment should not be initiated with this combination.

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - amlodipine besilate, quantity: 6.94 mg; perindopril arginine, quantity: 5 mg - tablet - excipient ingredients: crospovidone; microcrystalline cellulose; calcium hydrogen phosphate; trehalose dihydrate; glycerol dibehenate; sodium starch glycollate; light magnesium oxide; magnesium stearate - perindopril/amlodipine is indicated as substitution therapy for the treatment of hypertension and/or stable coronary heart disease in patients already controlled with separate doses of perindopril and amlodipine, given concurrently at the same dose level. treatment should not be initiated with this combination.

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - amlodipine besilate, quantity: 6.94 mg; perindopril arginine, quantity: 5 mg - tablet - excipient ingredients: sodium starch glycollate; magnesium stearate; crospovidone; glycerol dibehenate; microcrystalline cellulose; trehalose dihydrate; light magnesium oxide; calcium hydrogen phosphate - perindopril/amlodipine is indicated as substitution therapy for the treatment of hypertension and/or stable coronary heart disease in patients already controlled with separate doses of perindopril and amlodipine, given concurrently at the same dose level. treatment should not be initiated with this combination.

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - amlodipine besilate, quantity: 6.94 mg; perindopril arginine, quantity: 5 mg - tablet - excipient ingredients: sodium starch glycollate; glycerol dibehenate; microcrystalline cellulose; magnesium stearate; calcium hydrogen phosphate; crospovidone; trehalose dihydrate; light magnesium oxide - perindopril/amlodipine is indicated as substitution therapy for the treatment of hypertension and/or stable coronary heart disease in patients already controlled with separate doses of perindopril and amlodipine, given concurrently at the same dose level. treatment should not be initiated with this combination.

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - amlodipine besilate, quantity: 6.94 mg; perindopril arginine, quantity: 10 mg - tablet - excipient ingredients: glycerol dibehenate; sodium starch glycollate; calcium hydrogen phosphate; magnesium stearate; microcrystalline cellulose; light magnesium oxide; trehalose dihydrate; crospovidone - perindopril/amlodipine is indicated as substitution therapy for the treatment of hypertension and/or stable coronary heart disease in patients already controlled with separate doses of perindopril and amlodipine, given concurrently at the same dose level. treatment should not be initiated with this combination.